Medical Marijuana Aktie [WKN DE: A1C63S / ISIN: US58463A1051]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Medical Marijuana Inc.

17.08.17		Medical Marijuana, Inc. to Exhibit Only Federally Legal Product, Zero-THC Real Scientific Hemp Oil™, at ExpoWeed in Mexico City (PR Newswire)
16.08.17		Medicinal & Recreational Cannabis Companies Boosting Operations for Increasing Production to Meet Rising Demand (PR Newswire)
16.08.17		Vanity Fair Mexico Article Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico's Role in Improving Lives of Thousands of Patients (PR Newswire)
16.08.17		Medicinal & Recreational Cannabis Companies Boosting Operations for Increasing Production to Meet Rising Demand (PR Newswire)
14.08.17		Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Its Second Doctor Symposium on Medical Cannabis in Sao Paulo, Brazil (PR Newswire)
08.08.17		Medical Marijuana, Inc. Announces July 2017 as Largest Revenue Sales Month in Company History (PR Newswire)
07.08.17		Legal Cannabis and CBD Products Continues to Grow (PR Newswire)
04.08.17		Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes Second Brand Ambassador in Company History to Achieve International Director Title (PR Newswire)
03.08.17		Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related... (PR Newswire)
02.08.17		Senate Appropriations Committee Action Adds Fuel to the Fire for Businesses in the Legal Cannabis Space (PR Newswire)
02.08.17		Senate Appropriations Committee Action Adds Fuel to the Fire for Businesses in the Legal Cannabis Space (PR Newswire)
01.08.17		Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 25, 2017 Largest Revenue Day in Company History (PR Newswire)
01.08.17		Booming CBD Oil-based Product Market Continues to Experience Revenue Growth Month Over Month (PR Newswire)
01.08.17		Booming CBD Oil-based Product Market Continues to Experience Revenue Growth Month Over Month (PR Newswire)
31.07.17		Medical Marijuana, Inc. Commends Senate Appropriations Committee Renewal of the Rohrabacher-Farr Amendment (PR Newswire)
31.07.17		Legal Cannabis Product Sales Continues to Grow (PR Newswire)
27.07.17		Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Discusses Therapeutic Benefits of Cannabis During Annual International League Against Epilepsy Meeting (PR Newswire)
27.07.17		Medical Marijuana, Inc Major Investment AXIM Biotech Enters Agreement With Israel-Based CRO To Begin Clinical POC Study For Treatment Of Restless Leg Syndrome (PR Newswire)
26.07.17		Investment Options in the Multi-billion Dollar Medical Marijuana Industry (PR Newswire)
26.07.17		Investment Options in the Multi-billion Dollar Medical Marijuana Industry (PR Newswire)
25.07.17		Consumer Demand and Wave of Innovation in CBD Cannabis Market Exploding (PR Newswire)
25.07.17		Consumer Demand and Wave of Innovation in CBD Cannabis Market Exploding (PR Newswire)
24.07.17		Sales of CBD and Hemp Products are Projected to Grow (PR Newswire)
20.07.17		Medical Marijuana, Inc. and Subsidiary HempMeds Brasil™ Garners Vast Media Coverage Across Brazil of Company and Cannabis Market Growth (PR Newswire)
20.07.17		5 Standout Legal Cannabis Companies Worthy of Consideration (PR Newswire)
20.07.17		5 Standout Legal Cannabis Companies Worthy of Consideration (PR Newswire)
19.07.17		The Popularity of the Legal Cannabis Market Continues to Gain Globally (PR Newswire)
19.07.17		Amyotrophic Lateral Sclerosis (ALS) and Psoriasis Patients Receive Brazilian Government Permission to Be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™ (PR Newswire)
18.07.17		Cannabis Revenues Climb as Sales Demand Exceeds Legal Marijuana and CBD-based Product Supplies (PR Newswire)
18.07.17		Cannabis Revenues Climb as Sales Demand Exceeds Legal Marijuana and CBD-based Product Supplies (PR Newswire)
13.07.17		Rising Number of Medicinal and Recreational Cannabis Dispensaries Creating New Revenue Opportunities (PR Newswire)
13.07.17		Rising Number of Medicinal and Recreational Cannabis Dispensaries Creating New Revenue Opportunities (PR Newswire)
11.07.17		The Walt Disney Company Kicks Off Fourth Year of the Disney Accelerator (PR Newswire)
11.07.17		Adyen Named To Second Annual Forbes 2017 Cloud 100 List (PR Newswire)
11.07.17		Medical Marijuana, Inc. Announces Largest Revenue Quarter and Sales Month in Company History, 269% Revenue Increase From Q2 2016 (PR Newswire)
11.07.17		Cannabinoid Market Growth Expands With Rising Influence of Pharma and Biotech Science Advancements (PR Newswire)
11.07.17		Cannabinoid Market Growth Expands With Rising Influence of Pharma and Biotech Science Advancements (PR Newswire)
06.07.17		Forbes, Bloomberg, Global Press Cover Medical Marijuana, Inc. Subsidiary HempMeds® Mexico First Office Opening in Monterrey, Mexico (PR Newswire)
03.07.17		Medical Marijuana, Inc. Subsidiary Dixie Botanicals™ Appoints New Director of Sales and Marketing Brent Albin (PR Newswire)
29.06.17		Legal Cannabis Market Sales Continues to Trend (PR Newswire)
29.06.17		Medical Marijuana, Inc. Subsidiary Kannaway® Appoints New Vice President of Operations Jim Gibson (PR Newswire)
27.06.17		Reuters Features Medical Marijuana, Inc.'s Major Investment Company AXIM Biotech In Article Citing Company's Development Of Marijuana-Based Painkiller To Combat Opioid Crisis (PR Newswire)
27.06.17		CBD Based Products Fueling Cannabis Industry Revival (PR Newswire)
27.06.17		CBD Based Products Fueling Cannabis Industry Revival (PR Newswire)
26.06.17		Medical Marijuana, Inc. Major Investment AXIM Biotech Files Patent On Controlled Release Chewing Gum To Provide Opioid Addiction Treatment (PR Newswire)
22.06.17		Diverse Opportunities Aplenty for Investors Interested in the Marijuana Market (PR Newswire)
20.06.17		Legal Marijuana and CBD-based Products Increasing Demand Continues to Drive Revenue Growth (PR Newswire)
20.06.17		Legal Marijuana and CBD-based Products Increasing Demand Continues to Drive Revenue Growth (PR Newswire)
19.06.17		Medical Marijuana, Inc. Garners National News Coverage at 4th Annual Cannabis World Congress and Business Expo in New York (PR Newswire)
16.06.17		Sales of CBD-based Products Projected to Accelerate (PR Newswire)

Zurück | 1 | 2 | 3 | 4 | Weiter

Newssuche

Meistgelesene Nachrichten

Krypto-Influencer prognostiziert für 2025 gewaltige Rally beim Dogecoin

Solana Kurs-Prognose: 300 US-Dollar noch im Januar?

Neuer Stablecoin RLUSD: Ripple setzt auf globale Verfügbarkeit

SEC intensiviert Maßnahmen gegen Elon Musk und nimmt Neuralink unter die Lupe

Krypto-News: Während der Bitcoin konsolidiert pumpen Solana, Ripple und der Dogecoin

Zinspolitik 2025: EZB plant Senkungen - wie schnell kommen sie?

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	06.01.2025 10:48
Kaufwert:	EUR
	Hinzufügen Speichern